Published date:Mar 24 2025

Journal Title: Dubai Medical Journal

Issue title: Dubai Medical Journal (DMJ): Volume 8, Issue 1

Pages:48 - 56

DOI: 10.18502/dmj.v8i1.18314

Fatma Mohamed Al WahaibiDepartment of Obstetrics and Gynecology (OBGYN), University Medical City, Sultan Qaboos University Hospital and Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), Muscat

Raya Salim Al BusaidiRadiology Resident, Oman Medical Specialty Board, Muscat

Yasser MahfouzRadiology and Molecular Imaging Department, University Medical City, Sultan Qaboos University Hospital (SQUH), Muscat

Vaidyanathan Gowrigowri@squ.edu.omDepartment of Obstetrics and Gynecology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat

Ajit SebastianDepartment of Obstetrics and Gynecology, University Medical City, Sultan Qaboos University Hospital, Muscat

Introduction: Endometrial adenocarcinoma, usually seen in postmenopausal women, can also occur in younger patients and is often associated with polycystic ovarian syndrome (PCOS) and obesity.

Case Report: We report a case of a 33-year-old nulligravida woman with a 14-year history of subfertility, who presented with abdominal pain and a large abdominopelvic mass. While initial computed tomography (CT) imaging suggested ovarian malignancy, magnetic resonance imaging (MRI) revealed significant myometrial invasion, pointing to endometrial carcinoma. An endometrial biopsy confirmed grade 1 endometrioid adenocarcinoma, later staged as grade 2 stage 3 with positive pelvic lymph nodes after surgery.

Discussion: Though clinical examination was suggestive of ovarian tumors, imaging helped in the diagnosis of endometrial cancer and further management.

Conclusion: This case highlights the critical role of MRI in diagnosing endometrial carcinoma in younger women with atypical symptoms and underscores the importance of awareness among healthcare providers to suspect and appropriately investigate endometrial cancer in this population.

Keywords: gynecology, MRI, infertility, polycystic ovarian syndrome, obesity

[1] Son J, Carr C, Yao M, Radeva M, Priyadarshini A, Marquard J, et al. Endometrial cancer in young women: Prognostic factors and treatment outcomes in women aged ≤40 years. Int J Gynecol Cancer. 2020 May;30(5):631–639.

[2] Markowska A, Chudecka-Głaz A, Pityński K, Baranowski W, Markowska J, Sawicki W. Endometrial cancer management in young women. Cancers (Basel). 2022 Apr;14(8):1922.

[3] Rosen MW, Tasset J, Kobernik EK, Smith YR, Johnston C, Quint EH. Risk factors for endometrial cancer or hyperplasia in adolescents and women 25 years old or younger [PubMed,CrossRef,Google Scholar]. J Pediatr Adolesc Gynecol. 2019 Oct;32(5):546–549.

[4] Mukerji B, Baptiste C, Chen L, Tergas AI, Hou JY, Ananth CV, et al. Racial disparities in young women with endometrial cancer. Gynecol Oncol. 2018 Mar;148(3):527–534.

[5] Mukuda N, Fujii S, Inoue C, Fukunaga T, Oishi T, Harada T, et al. Bilateral ovarian tumors on MRI: How should we differentiate the lesions? Yonago Acta Med. 2018 Jun;61(2):110–116.

[6] Tanaka YO, Okada S, Satoh T, Matsumoto K, Oki A, Saida T, et al. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis. Cancer Imaging. 2016 Feb;16(3):3.

[7] Xu Y, Yang J, Zhang Z, Zhang G. MRI for discriminating metastatic ovarian tumors from primary epithelial ovarian cancers. J Ovarian Res. 2015 Aug;8(1):61.

[8] Bi Q, Chen Y, Wu K, Wang J, Zhao Y, Wang B, et al. The diagnostic value of MRI for preoperative staging in patients with endometrial cancer: A meta-analysis. Acad Radiol. 2020 Jul;27(7):960–968.

[9] Madár I, Szabó A, Vleskó G, Hegyi P, Ács N, Fehérvári P, et al. Diagnostic accuracy of transvaginal ultrasound and magnetic resonance imaging for the detection of myometrial infiltration in endometrial cancer: A systematic review and meta-analysis. Cancers (Basel). 2024 Feb;16(5):907.

[10] Daoud T, Sardana S, Stanietzky N, Klekers AR, Bhosale P, Morani AC. Recent imaging updates and advances in gynecologic malignancies. Cancers (Basel). 2022 Nov;14(22):5528.

[11] Johnson JE, Daley D, Tarta C, Stanciu PI. Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta-analysis. Oncol Lett. 2023 Mar;25(4):168.

[12] Fanta M. Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogendependant malignancies? Gynecol Endocrinol. 2013 Feb;29(2):145–147.

[13] Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: An Australian case-control study. Cancer Causes Control. 2010 Dec;21(12):2303–2308.